Harvard Bioscience, Inc. (HBIO)
8.46
-0.10
(-1.17%)
USD |
NASDAQ |
Oct 07, 16:00
8.46
0.00 (0.00%)
After-Hours: 18:03
Harvard Bioscience Gross Profit Margin (Quarterly) : 51.96% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 51.96% |
| March 31, 2026 | 55.04% |
| December 31, 2025 | 56.13% |
| September 30, 2025 | 54.23% |
| June 30, 2025 | 50.71% |
| March 31, 2025 | 50.63% |
| December 31, 2024 | 51.94% |
| September 30, 2024 | 52.03% |
| June 30, 2024 | 51.47% |
| March 31, 2024 | 54.83% |
| December 31, 2023 | 53.06% |
| September 30, 2023 | 52.70% |
| June 30, 2023 | 53.15% |
| March 31, 2023 | 56.57% |
| December 31, 2022 | 50.49% |
| September 30, 2022 | 44.28% |
| June 30, 2022 | 51.98% |
| March 31, 2022 | 51.12% |
| December 31, 2021 | 54.78% |
| September 30, 2021 | 50.06% |
| June 30, 2021 | 50.99% |
| March 31, 2021 | 51.75% |
| December 31, 2020 | 52.47% |
| September 30, 2020 | 50.41% |
| June 30, 2020 | 53.21% |
| Date | Value |
|---|---|
| March 31, 2020 | 48.61% |
| December 31, 2019 | 50.94% |
| September 30, 2019 | 49.45% |
| June 30, 2019 | 49.08% |
| March 31, 2019 | 52.21% |
| December 31, 2018 | 51.21% |
| September 30, 2018 | 50.08% |
| June 30, 2018 | 44.18% |
| March 31, 2018 | 46.09% |
| December 31, 2017 | 49.09% |
| September 30, 2017 | 48.62% |
| June 30, 2017 | 45.84% |
| March 31, 2017 | 50.87% |
| December 31, 2016 | 43.47% |
| September 30, 2016 | 43.83% |
| June 30, 2016 | 42.03% |
| March 31, 2016 | 45.49% |
| December 31, 2015 | 43.15% |
| September 30, 2015 | 42.98% |
| June 30, 2015 | 41.38% |
| March 31, 2015 | 41.47% |
| December 31, 2014 | 43.22% |
| September 30, 2014 | 42.53% |
| June 30, 2014 | 43.37% |
| March 31, 2014 | 42.97% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 55.48% |
| Bio-Rad Laboratories, Inc. | 53.12% |
| Bruker Corp. | 49.65% |
| Danaher Corp. | 57.64% |
| Illumina, Inc. | 66.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -85.35% |
| Return on Assets | -13.27% |
| Return on Invested Capital | -18.61% |
| Profit Margin (Quarterly) | -12.80% |
| Operating Margin (Quarterly) | -2.90% |
| Return on Net Operating Assets | -16.01% |